Inventor
Hong Wu
Inventor
New Hope, PA, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds37%
A61KPreparations for medical, dental or toiletry purposes14%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
Y02PClimate change mitigation technologies in the production or processing of goods3%
H10NElectric solid-state devices not otherwise provided for2%
LOC152%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
PatentTitleYear
10,975,082Inhibitor of FLT3 kinase and use thereof202110,781,214Kinase inhibitor against wild-type and mutant EGFR202010,669,238Irreversible bruton's tyrosine kinase inhibitor202010,618,903Heteroaryl substituted aminopyridine compounds202010,544,133Heteroaryl substituted pyridyl compounds useful as kinase modulators202010,350,210EGFR and ALK dual inhibitor201910,294,229Heteroaryl substituted aminopyridine compounds201910,266,535Inhibitor of FLT3 kinase and use thereof201910,202,390Heteroaryl substituted aminopyridine compounds2019D0840449Twisted drill bit tip201910,023,562Heteroaryl substituted pyridyl compounds useful as kinase modulators20189,814,709'Bruton\'s tyrosine kinase inhibitor'20179,657,009'Heteroaryl substituted pyridyl compounds useful as kinase modulators'20179,546,153'Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators'20179,221,826'Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases'20159,169,252'Heteroaryl substituted nicotinamide compounds'20158,987,268'Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases'20158,921,368'Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases'20148,410,139'Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity'20138,338,604'Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors'20127,642,257'Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors'20107,419,978'Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors'20087,323,482'Thiazolyl-based compounds useful as kinase inhibitors'20087,169,771'Thiazolyl-based compounds useful as kinase inhibitors'20076,653,304'Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases'20035,156,004'Composite semiconductive thermoelectric refrigerating device'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2020Patents assigned to BRISTOL MYERS SQUIBB CO (18)· patent assignee history
2003Based in Lawrenceville, NJ, US· patent location history
2007–2020Based in New Hope, PA, US· patent location history
2012–2015Patents assigned to HYNES JOHN (5)· patent assignee history
2012–2015Patents assigned to WU HONG (5)· patent assignee history
2014–2015Patents assigned to GUO JUNQING (3)· patent assignee history
2017–2020Patents assigned to HEFEI INST PHYSICAL SCI CAS (3)· patent assignee history
2017Based in Hefei, CN· patent location history
2019–2021Based in Anhui, CN· patent location history
2019Based in Shanghai, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 18 | 2003–2020 |
| HYNES JOHN | 5 | 2012–2015 |
| WU HONGself | 5 | 2012–2015 |
| GUO JUNQING | 3 | 2014–2015 |
| HEFEI INST PHYSICAL SCI CAS | 3 | 2017–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| New Hope, Pennsylvania, US | 17 | 2007–2020 |
| Anhui, CN | 5 | 2019–2021 |
| Shanghai, CN | 1 | 2019 |
| Hefei, CN | 1 | 2017 |
| Lawrenceville, New Jersey, US | 1 | 2003 |